Skip to content
Open access

Integrated experimental and network pharmacology evaluation of a defined phytochemical combination in diabetes-related models.

Oct 2026 · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · Vol 204, pp. 119966 · 0 citations · 39 references
Medicine

Abstract

Aim

This study evaluated a predefined combination of curcumin, quercetin, forskolin, and gymnemic acid using both experimental and computational approaches.

Methods

The phytochemical combination of curcumin, quercetin, forskolin, gymnemic acid was assessed through diabetes-related enzyme inhibition and free radical scavenging assays. Acute and 90-day oral toxicity studies were conducted to evaluate safety. Two independent cohorts of rats induced with streptozotocin one over 120 days and the other over 90 day- were used to examine outcomes related to glycaemia, biochemistry, oxidative stress, inflammation, histology, and pancreatic insulin-immunoreactivity outcomes. Network pharmacology and molecular docking methods were employed to generate mechanistic hypotheses.

Results

PCC inhibited the activities of α-amylase, α-glucosidase, DPP-IV, and aldose reductase. Inhibition of glucose-6-phosphatase, PTP1B, cholesterol esterase, and pancreatic lipase was minimal or undetected. PCC demonstrated scavenging activity against DPPH and ABTS radicals. No consistent treatment-related toxicity was observed during the 90 days of dosing at doses up to 600 mg/kg/day, the highest tested. Both streptozotocin cohorts showed that PCC improved glycaemia and some selected metabolic and oxidative stress measures, as well as pancreatic insulin immunoreactivity and inflammatory markers; however, these findings do not indicate β-cell regeneration or a mechanism for type 2 diabetes. Network and docking analyses generated only predicted associations.

Conclusion

The predefined PCC exhibited selective inhibition of diabetes-related enzymes, demonstrated free radical scavenging activity, and showed preliminary effects in vivo. The computational findings are exploratory but hypothesis-generating and require pharmacokinetic and molecular validation. Neither synergy nor direct engagement of the predicted molecular targets was established.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.